v3.26.3
Earnings Per Share
9 Months Ended
Sep. 30, 2026
Earnings Per Share [Abstract]  
Earnings Per Share
Note 7 - Earnings Per Share
The following table sets forth the reconciliation of the numerator and the denominator of basic earnings per share and diluted earnings per share for the three and nine months ended September 30, 2026 and 2025:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026202520262025
Numerator:
Net income attributable to The Timken Company$93.8 $69.3 $220.9 $226.1 
Denominator:
Weighted average number of shares outstanding -
   basic
69,194,568 69,650,093 69,409,887 69,810,153 
Effect of dilutive securities:
Stock options and awards - based on the treasury
   stock method
635,228 457,098 626,215 423,106 
Weighted average number of shares outstanding
   assuming dilution of stock options and awards
69,829,796 70,107,191 70,036,102 70,233,259 
Basic earnings per share$1.36 $0.99 $3.18 $3.24 
Diluted earnings per share $1.34 $0.99 $3.15 $3.22 
The dilutive effect of performance-based restricted stock units is taken into account once they have met minimum performance thresholds. The dilutive effect of stock options includes all outstanding stock options except stock options that are considered antidilutive. Stock options are antidilutive when the exercise price exceeds the average market price of the Company’s common shares during the periods presented. There were no antidilutive stock options outstanding during the three and nine months ended September 30, 2026 and 2025. There were no antidilutive stock awards, including performance-based restricted stock units and restricted stock units, outstanding during the three months ended September 30, 2026, and there were 794 antidilutive stock awards outstanding during the nine months ended September 30, 2026. In addition, there were 58,460 and 66,550 antidilutive stock awards, including performance-based restricted stock units and restricted stock units, outstanding during the three and nine months ended September 30, 2025, respectively.